ABCB1 and cancer: Modern studies pointed that its anti-proliferative action on cancer cells may involve the cell cycle arrest in the S-phase and inhibition of protein synthesis [5] but also cytotoxic activity towards human monocytes and skin tissues [6] and that it is effluxed by P-glycoprotein (P-gp) [7], thus limiting its therapeutic potential.